Company
Anxo Pharmaceutical Co. Ltd
Headquarters: Taipei, Taiwan
Market Cap
TW$2.69 Billion
TWD as of Jan. 1, 2024
US$87.8 Million
Anxo Pharmaceutical Co. Ltd Categories
Taiwan Healthcare Drug Manufacturers—Specialty & GenericTaiwan Healthcare Taiwan Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. It offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, gastroenterology, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. The company was founded in 2003 and is headquartered in Taipei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Anxo Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 6677 wb_incandescent